181 related articles for article (PubMed ID: 37887278)
21. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.
Lane NE
Curr Osteoporos Rep; 2019 Feb; 17(1):1-7. PubMed ID: 30685820
[TBL] [Abstract][Full Text] [Related]
23. Osteoblast autophagy in glucocorticoid-induced osteoporosis.
Wang L; Heckmann BL; Yang X; Long H
J Cell Physiol; 2019 Apr; 234(4):3207-3215. PubMed ID: 30417506
[TBL] [Abstract][Full Text] [Related]
24. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation.
Rauch A; Gossye V; Bracke D; Gevaert E; Jacques P; Van Beneden K; Vandooren B; Rauner M; Hofbauer LC; Haegeman G; Elewaut D; Tuckermann JP; De Bosscher K
FASEB J; 2011 Apr; 25(4):1323-32. PubMed ID: 21233489
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y1 Receptor Regulates Glucocorticoid-Induced Inhibition of Osteoblast Differentiation in Murine MC3T3-E1 Cells via ERK Signaling.
Yu W; Zhu C; Xu W; Jiang L; Jiang S
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 28009825
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.
O'Brien CA; Jia D; Plotkin LI; Bellido T; Powers CC; Stewart SA; Manolagas SC; Weinstein RS
Endocrinology; 2004 Apr; 145(4):1835-41. PubMed ID: 14691012
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.
Subramaniam M; Colvard D; Keeting PE; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1992 Dec; 50(4):411-24. PubMed ID: 1469072
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of glucocorticoid-induced osteoporosis.
Canalis E
Curr Opin Rheumatol; 2003 Jul; 15(4):454-7. PubMed ID: 12819474
[TBL] [Abstract][Full Text] [Related]
30. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid-Induced Osteoporosis.
Frenkel B; White W; Tuckermann J
Adv Exp Med Biol; 2015; 872():179-215. PubMed ID: 26215995
[TBL] [Abstract][Full Text] [Related]
32. Different susceptibilities of osteoclasts and osteoblasts to glucocorticoid-induced oxidative stress and mitochondrial alterations.
Chen YH; Peng SY; Cheng MT; Hsu YP; Huang ZX; Cheng WT; Wu SC
Chin J Physiol; 2019; 62(2):70-79. PubMed ID: 31243177
[TBL] [Abstract][Full Text] [Related]
33. WNT7B overexpression rescues bone loss caused by glucocorticoids in mice.
Chen H; Song F; Long F
FASEB J; 2021 Jul; 35(7):e21683. PubMed ID: 34118078
[TBL] [Abstract][Full Text] [Related]
34. Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
Horsch K; de Wet H; Schuurmans MM; Allie-Reid F; Cato AC; Cunningham J; Burrin JM; Hough FS; Hulley PA
Mol Endocrinol; 2007 Dec; 21(12):2929-40. PubMed ID: 17761948
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1-integrin levels.
Gronowicz GA; McCarthy MB
Endocrinology; 1995 Feb; 136(2):598-608. PubMed ID: 7530648
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoids inhibit the maturation of committed osteoblasts via SOX2.
Chen JH; Shen C; Oh HR; Park JH
J Mol Endocrinol; 2022 Apr; 68(4):195-207. PubMed ID: 35255002
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of glucocorticoid action in bone cells.
Delany AM; Dong Y; Canalis E
J Cell Biochem; 1994 Nov; 56(3):295-302. PubMed ID: 7876321
[TBL] [Abstract][Full Text] [Related]
38. Tocotrienol as a Protecting Agent against Glucocorticoid-Induced Osteoporosis: A Mini Review of Potential Mechanisms.
Ekeuku SO; Mohd Ramli ES; Abdullah Sani N; Abd Ghafar N; Soelaiman IN; Chin KY
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144598
[TBL] [Abstract][Full Text] [Related]
39. The skeletal effects of glucocorticoid excess override those of orchidectomy in mice.
Weinstein RS; Jia D; Powers CC; Stewart SA; Jilka RL; Parfitt AM; Manolagas SC
Endocrinology; 2004 Apr; 145(4):1980-7. PubMed ID: 14715712
[TBL] [Abstract][Full Text] [Related]
40. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
